about
A review of anti-inflammatory agents for symptoms of schizophreniaCelecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On TrialsThe neuroimmunology of schizophreniaInvestigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization StudyEvolutionary biology and anthropology suggest biome reconstitution as a necessary approach toward dealing with immune disordersMutation analysis of the C1QTNF3 gene in patients with schizophreniaAutoimmune diseases, bipolar disorder, and non-affective psychosisImaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia.Revisiting thyroid hormones in schizophreniaAssociations of high sensitivity C-reactive protein levels in schizophrenia and comparison groupsElevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia.Inflammation and Elevation of Interleukin-12p40 in Patients with Schizophrenia.From gut dysbiosis to altered brain function and mental illness: mechanisms and pathwaysSpatial characteristics of white matter abnormalities in schizophrenia.Treatment of schizophrenia in the 21st Century: beyond the neurotransmitter hypothesis.Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia?Immune dysregulation and autoimmunity in bipolar disorder: Synthesis of the evidence and its clinical application.Coupling physical exercise with dietary glucose supplement for treating cognitive impairment in schizophrenia: a theoretical model and future directions.Disrupted Circadian Rhythm as a Common Player in Developmental Models of Neuropsychiatric Disorders.Inflammatory processes and schizophrenia: two independent lines of evidence from a study of twins discordant and concordant for schizophrenic disorders.Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia.Salsalate as an adjunctive treatment for psychopathology and cognition in patients with schizophrenia: a pilot study.Protein-C reactive as biomarker predictor of schizophrenia phases of illness? A systematic review.The Communication Between the Immune and Nervous Systems: The Role of IL-1β in Synaptopathies.Altered Serum Tumor Necrosis Factor and Interleukin-1β in First-Episode Drug-Naive and Chronic Schizophrenia.Recent advances in psychoneuroimmunology: Inflammation in psychiatric disordersHuman Endogenous Retroviral Envelope Protein Syncytin-1 and Inflammatory Abnormalities in Neuropsychological Diseases
P2860
Q22241827-1A9799C1-32FA-4A95-A551-7525EF71B33CQ26741541-5B42D442-9500-4EB6-995B-81D515FAE492Q26859392-47498FFC-3667-4983-B077-D2E56F7A9549Q28600936-F130706B-AC38-4E05-9731-C59CEA03E58EQ30048092-8951097E-57FD-4BC2-AD5A-05280466B2B4Q34077414-1A87EFB7-9168-44A5-8E8B-06738F5DFADAQ34179648-D41F6804-4447-47A9-BFC9-0A87EC83708EQ34701163-2385989E-1B25-4487-B1D2-844CE5912440Q34830625-0066AA79-1480-4D15-A1AD-32700BB71340Q35876138-F20118F3-C5B4-4CE1-829B-BBB9F020846DQ36113651-42829D82-D9E7-4779-8A1C-CFB1E7B8966DQ36579965-96BD4A34-1EED-41F9-AADB-C9FAFAF1DB84Q36600804-8ADF3CE2-C422-4959-B853-E015365AF256Q36712400-23A51902-6962-4360-AD94-EEE1800CB467Q36932850-49148360-C1A4-4FFB-8AF0-E2B2D3735215Q37131036-1C2F83C2-C954-4DAE-B3A9-E8D1B367B572Q37356489-5770045F-83E2-4B12-A083-3ED1171F699BQ37721268-22E3A58A-6DED-42E4-B912-806A36231F39Q38125979-4F58758D-5ECD-4A4D-89AF-4882598DDCAFQ38162296-7773FA57-2ED1-4910-A07C-45E65EEA719EQ38686115-60A63EC9-DD75-40B3-864D-C777999A8581Q38854101-5F0DEF2A-78D4-4E14-9011-BA718AB292A4Q47194564-BC1300D5-5EA6-4729-99C9-AA25EF74BBB1Q47230781-B3028F4F-C37C-440C-B815-AE88E7C56784Q47553108-F7A509D5-7D73-41CF-9A2C-44608E8865FAQ52314919-D076BA4B-381F-4103-8DF1-F130CBF0B5D7Q55438770-1AD8839C-3736-4C59-B68A-2B83870ECD2BQ57844416-7A83E187-B8FF-4076-83AD-1F5E57B393CCQ58758788-3106DA4D-FB8E-4927-8DF0-FBA4FEE65E65
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Inflammation and schizophrenia.
@en
type
label
Inflammation and schizophrenia.
@en
prefLabel
Inflammation and schizophrenia.
@en
P2860
P356
P1476
Inflammation and schizophrenia.
@en
P2093
David C Henderson
Xiaoduo Fan
P2860
P304
P356
10.1586/14737175.7.7.789
P577
2007-07-01T00:00:00Z